Comments
Torrent Pharma posted a 1 per cent dip in net profit at ₹204 crore for the quarter ended September 2017 as against ₹207 crore reported in the corresponding quarter a year ago.
Company's revenues for the quarter stood at ₹1,429 crore.
EBIDTA was at ₹405 crore as against ₹372 crore during the same period last year, showing 9 per cent growth.
In the first half period of April-September, the company reported a 21 per cent dip in net profit at ₹392 crore, against ₹499 crore reported in the same period last year.
Revenues for the period fell 6 per cent to ₹2,803 crore, against ₹2,980 crore in the corresponding period a year ago.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.